Obstructive – Nonobstructive hypertrophic cardiomyopathy: differences and predictors

References

• Elliott PM, Anastasakis A, Borger MA, et al. ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the european society of cardiology (ESC). Eur Heart J. 2014;35(39):2733–2779.
   PubMed Web of Science ®Google Scholar
• Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines. Circulation. 2020;142(25):e558–e631.
   PubMed Web of Science ®Google Scholar
• Burns J, Jean-Pierre P. Disparities in the diagnosis of hypertrophic obstructive cardiomyopathy: a narrative review of current literature. Cardiol Res Pract. 2018;2018:3750879. doi: 10.1155/2018/3750879.
   PubMed Web of Science ®Google Scholar
• Aguiar Rosa S, Rocha Lopes L, Fiarresga A, et al. Coronary microvascular dysfunction in hypertrophic cardiomyopathy: pathophysiology, assessment, and clinical impact. Microcirculation. 2021;28(1):e12656. doi: 10.1111/micc.12656.
   PubMed Web of Science ®Google Scholar
• Semsarian C, Ingles J, Maron MS, et al. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249–1254. doi: 10.1016/j.jacc.2015.01.019.
   PubMed Web of Science ®Google Scholar
• Russo D, Sclafani M, Tini G, et al. Prognostic implications of different clinical profiles in hypertrophic cardiomyopathy. Minerva Cardiol Angiol. 2022;70(2):189–206. doi: 10.23736/S2724-5683.21.05752-5.
   PubMedGoogle Scholar
• Geske JB, Ommen SR, Gersh BJ. Hypertrophic cardiomyopathy: clinical update. J Am Coll Cardiol HF. 2018;6:364–375.
   Google Scholar
• Maron BJ. Clinical course and management of hypertrophic cardiomyopathy. N Engl J Med. 2018;379(7):655–668. doi: 10.1056/NEJMra1710575.
   PubMed Web of Science ®Google Scholar
• Arnett DK, Goodman RA, Halperin JL, et al. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US department of health and human services. Circulation. 2014;130(18):1662–1667. doi: 10.1161/CIR.0000000000000128.
   PubMed Web of Science ®Google Scholar
• Levine GN, O'Gara PT, Beckman JA, et al. Recent innovations, modifications, and evolution of ACC/AHA clinical practice guidelines: an update for our constituencies: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. 2019;139(17):e879–e886. doi: 10.1161/CIR.0000000000000651.
   PubMed Web of Science ®Google Scholar
• Weissler-Snir A, Allan K, Cunningham K, et al. Hypertrophic cardiomyopathy-related sudden cardiac death in young people in Ontario. Circulation. 2019;140(21):1706–1716. doi: 10.1161/CIRCULATIONAHA.119.040271.
   PubMed Web of Science ®Google Scholar
• Kwon DH, Setser RM, Thamilarasan M, et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy. Heart. 2008;94(10):1295–1301. doi: 10.1136/hrt.2007.118018.
   PubMed Web of Science ®Google Scholar
• Geske JB, Sorajja P, Ommen SR, et al. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy. JACC Cardiovasc Interv. 2011;4(6):704–709. doi: 10.1016/j.jcin.2011.02.014.
   PubMed Web of Science ®Google Scholar
• Arbelo E, Protonotarios A, Gimeno JR, et al. ESC scientific document group. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J. 2023;44(37):3503–3626. doi: 10.1093/eurheartj/ehad194.
   Google Scholar
• Almenar L, Martí S, Roldán I, et al. Miocardiopatía hipertrófica obstructiva y no obstructiva: diferencias clínicas, electrocardiográficas y ecocardiográficas [obstructive and non-obstructive hypertrophic cardiomyopathy: clinical, electrocardiographic, and echocardiographic differences]. Rev Esp Cardiol. 1996;49(6):423–431.
   PubMedGoogle Scholar
• Pozios I, Corona-Villalobos C, Sorensen LL, et al. Comparison of outcomes in patients with nonobstructive, labile-obstructive, and chronically obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2015;116(6):938–944. doi: 10.1016/j.amjcard.2015.06.018.
   PubMed Web of Science ®Google Scholar
• Tesic M, Beleslin B, Giga V, et al. Characteristics and outcomes of elderly patients with hypertrophic cardiomyopathy. J Am Heart Assoc. 2021;10(20):e018527. Feb 2
   PubMedGoogle Scholar
• Kis M, Dogan Y, Yildirim A, et al. LVH-TR study collaborates. Evaluation of demographic, clinical, and aetiological data of patients admitted to cardiology clinics and diagnosed with left ventricular hypertrophy in turkish population (LVH-TR). Acta Cardiol. 2022;12:1–10.
   Google Scholar
• Chua KCM, Rusinaru C, Reinier K, et al. Tpeak-to-tend interval corrected for heart rate: a more precise measure of increased sudden death risk? Heart Rhythm. 2016;13(11):2181–2185. Novdoi: 10.1016/j.hrthm.2016.08.022.
   PubMed Web of Science ®Google Scholar
• Hancock EW, Deal BJ, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the ınternational society for computerized electrocardiology. J Am Coll Cardiol. 2009;53(11):992–1002. doi: 10.1016/j.jacc.2008.12.015.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1.e14–39.e14. doi: 10.1016/j.echo.2014.10.003.
   Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339.
   PubMed Web of Science ®Google Scholar
• van Driel B, Nijenkamp L, Huurman R, et al. Sex differences in hypertrophic cardiomyopathy: new insights. Curr Opin Cardiol. 2019;34(3):254–259. doi: 10.1097/HCO.0000000000000612.
   PubMed Web of Science ®Google Scholar
• Maron MS, Olivotto I, Betocchi S, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348(4):295–303. doi: 10.1056/NEJMoa021332.
   PubMed Web of Science ®Google Scholar
• Huurman R, Schinkel AFL, van der Velde N, et al. Effect of body surface area and gender on wall thickness thresholds in hypertrophic cardiomyopathy. Neth Heart J. 2020;28(1):37–43. doi: 10.1007/s12471-019-01349-1.
   PubMed Web of Science ®Google Scholar
• Robertson J, Schaufelberger M, Lindgren M, et al. Higher body mass ındex in adolescence predicts cardiomyopathy risk in midlife. Circulation. 2019;140(2):117–125. doi: 10.1161/CIRCULATIONAHA.118.039132.
   PubMed Web of Science ®Google Scholar
• Zhou K, Xiang J, Li GY, et al. Body composition and mortality in a cohort study of chinese patients with hypertrophic cardiomyopathy. Front Cardiovasc Med. 2023;10:988274. doi: 10.3389/fcvm.2023.988274.
   PubMed Web of Science ®Google Scholar
• Sun D, Schaff HV, Nishimura RA, et al. Impact of body mass ındex on outcome of septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg. 2022;113(2):519–526. doi: 10.1016/j.athoracsur.2021.03.038.
   PubMed Web of Science ®Google Scholar
• Pelliccia A, Di Paolo FM, Quattrini FM, et al. Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med. 2008;358(2):152–161. doi: 10.1056/NEJMoa060781.
   PubMed Web of Science ®Google Scholar
• Caselli S, Pelliccia A. The electrocardiogram and the phenotypic expression of hypertrophic cardiomyopathy. Eur Heart J. 2019;40(12):982–985. doi: 10.1093/eurheartj/ehy403.
   PubMed Web of Science ®Google Scholar
• Higuchi S, Minami Y, Shoda M, et al. Prognostic ımplication of first-degree atrioventricular block in patients with hypertrophic cardiomyopathy. J Am Heart Assoc. 2020;9(6):e015064.
   PubMed Web of Science ®Google Scholar
• Bula K, Bisaga J, Feret B, et al. Electro- and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy. Ann Noninvasive Electrocardiol. 2022;27(5):e12992. doi: 10.1111/anec.12992.
   PubMed Web of Science ®Google Scholar
• Robyns T, Nuyens D, Lu HR, et al. Prognostic value of electrocardiographic time intervals and QT rate dependence in hypertrophic cardiomyopathy. J Electrocardiol. 2018;51(6):1077–1083. doi: 10.1016/j.jelectrocard.2018.09.005.
   PubMed Web of Science ®Google Scholar
• Rattanawong P, Riangwiwat T, Kanitsoraphan C, et al. Baseline fragmented QRS increases the risk of major arrhythmic events in hypertrophic cardiomyopathy: systematic review and meta-analysis. Ann Noninvasive Electrocardiol. 2018;23(4):e12533. doi: 10.1111/anec.12533.
   PubMed Web of Science ®Google Scholar
• Bignoto TC, Moreira DAR, Habib RG, et al. Electrocardiography scar quantification correlates with scar size of hypertrophic cardiomyopathy seen by multidetector computed tomography. Clin Cardiol. 2018;41(6):837–842. doi: 10.1002/clc.22966.
   PubMed Web of Science ®Google Scholar
• Johnson JN, Grifoni C, Bos JM, et al. Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy. Eur Heart J. 2011;32(9):1114–1120. doi: 10.1093/eurheartj/ehr021.
   PubMed Web of Science ®Google Scholar
• Kashou AH, Basit H, Malik A. ST segment. In: StatPearls [Internet]. Treasure Island (FL): statPearls Publishing; 2022.
   Google Scholar
• Rautaharju PM, Surawicz B, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the ınternational society for computerized electrocardiology. J Am Coll Cardiol. 2009;53(11):982–991. doi: 10.1016/j.jacc.2008.12.014.
   PubMed Web of Science ®Google Scholar
• Olivotto I, Maron MS, Autore C, et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2008;52(7):559–566. doi: 10.1016/j.jacc.2008.04.047.
   PubMed Web of Science ®Google Scholar
• Lu DY, Haileselassie B, Ventoulis I, et al. E/e’ ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction. Eur Heart J Cardiovasc Imaging. 2018;19(1):101–107. doi: 10.1093/ehjci/jex134.
   PubMed Web of Science ®Google Scholar
• Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American society of echocardiography and the european association of cardiovascular ımaging. J Am Soc Echocardiogr. 2016;29(4):277–314. Aprdoi: 10.1016/j.echo.2016.01.011.
   PubMed Web of Science ®Google Scholar